(Q47447132)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Chu Kiong Loo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Colleen K. Loo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Cynthia Shannon Weickert

11

object named as

C S Weickert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

V Gálvez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

E O'Keefe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

D Hadzi-Pavlovic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

J Leyden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S Harper

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

A A Somogyi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

R Lai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

P Glue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

English

0 references

publication date

30 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

48-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A randomized controlled trial of intranasal ketamine in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Pilot dose-response trial of i.v. ketamine in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Acute antidepressant effects of intramuscular versus intravenous ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Dose- and exposure-response to ketamine in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12572

21 January 2018

Identifiers

DOI

10.1111/ACPS.12572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27028832%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference